194 related articles for article (PubMed ID: 11520149)
1. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system.
Massad LS; Collins YC; Meyer PM
Gynecol Oncol; 2001 Sep; 82(3):516-22. PubMed ID: 11520149
[TBL] [Abstract][Full Text] [Related]
2. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
3. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology.
Mayeaux EJ; Harper MB; Abreo F; Pope JB; Phillips GS
J Fam Pract; 1995 Jan; 40(1):57-62. PubMed ID: 7807039
[TBL] [Abstract][Full Text] [Related]
5. The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?
Pretorius RG; Belinson JL; Zhang WH; Burchette RJ; Elson P; Qiao YL
J Reprod Med; 2001 Aug; 46(8):724-8. PubMed ID: 11547646
[TBL] [Abstract][Full Text] [Related]
6. Low-grade Papanicolaou smears and the Bethesda system: a prospective cytohistopathologic analysis.
Lonky NM; Navarre GL; Saunders S; Sadeghi M; Wolde-Tsadik G
Obstet Gynecol; 1995 May; 85(5 Pt 1):716-20. PubMed ID: 7724102
[TBL] [Abstract][Full Text] [Related]
7. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
8. Should all women with cervical atypia be referred for colposcopy: a HARNET study. Harrisburgh Area Research Network.
Slawson DC; Bennett JH; Simon LJ; Herman JM
J Fam Pract; 1994 Apr; 38(4):387-92. PubMed ID: 8163964
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
Kaufman RH; Adam E; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
[TBL] [Abstract][Full Text] [Related]
10. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
[TBL] [Abstract][Full Text] [Related]
11. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
12. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
[TBL] [Abstract][Full Text] [Related]
13. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.
ASCUS-LSIL Traige Study (ALTS) Group
Am J Obstet Gynecol; 2003 Jun; 188(6):1383-92. PubMed ID: 12824967
[TBL] [Abstract][Full Text] [Related]
14. Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing.
Paraskevaidis E; Malamou-Mitsi V; Koliopoulos G; Pappa L; Lolis E; Georgiou I; Agnantis NJ
Gynecol Oncol; 2001 Aug; 82(2):355-9. PubMed ID: 11531293
[TBL] [Abstract][Full Text] [Related]
15. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of atypical and low-grade cervical cytology in private practice.
Nyirjesy I; Billingsley FS; Forman MR
Obstet Gynecol; 1998 Oct; 92(4 Pt 1):601-7. PubMed ID: 9764636
[TBL] [Abstract][Full Text] [Related]
17. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
[TBL] [Abstract][Full Text] [Related]
18. Cervicography combined with repeat Papanicolaou test as triage for low-grade cytologic abnormalities.
Eskridge C; Begneaud WP; Landwehr C
Obstet Gynecol; 1998 Sep; 92(3):351-5. PubMed ID: 9721768
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results.
Lonky NM; Sadeghi M; Tsadik GW; Petitti D
Am J Obstet Gynecol; 1999 Sep; 181(3):560-6. PubMed ID: 10486464
[TBL] [Abstract][Full Text] [Related]
20. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear.
Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
Acta Cytol; 2007; 51(5):755-66. PubMed ID: 17910346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
